APA (7th ed.) Citation

Park, Y. H., Pyun, J., Hodges, A., Jang, J., Bice, P. J., Kim, S., . . . Initiative, f. t. A. c. a. t. A. D. N. (2021). Dysregulated expression levels of APH1B in peripheral blood are associated with brain atrophy and amyloid-β deposition in Alzheimer’s disease. BMC.

Chicago Style (17th ed.) Citation

Park, Young Ho, Jung-Min Pyun, Angela Hodges, Jae-Won Jang, Paula J. Bice, SangYun Kim, Andrew J. Saykin, Kwangsik Nho, and for the AddNeuroMed consortium and the Alzheimer’s Disease Neuroimaging Initiative. Dysregulated Expression Levels of APH1B in Peripheral Blood Are Associated with Brain Atrophy and Amyloid-β Deposition in Alzheimer’s Disease. BMC, 2021.

MLA (8th ed.) Citation

Park, Young Ho, et al. Dysregulated Expression Levels of APH1B in Peripheral Blood Are Associated with Brain Atrophy and Amyloid-β Deposition in Alzheimer’s Disease. BMC, 2021.